Myalepta (metreleptin)

pCPA File Number: 22611

Negotiation Status:

Under consideration for negotiation

Indication(s):

Leptin deficiency in lipodystrophy

Sponsor/Manufacturer:

Medison Pharma Canada Inc.

CDA-AMC Project Number:

SR0784-000

pCPA Engagement Letter Issued:

Not Applicable

Negotiation Process Concluded:

Not Applicable